MenaQ7® is the natural, clinically proven Vitamin K2 as MK-7, backed by nearly two decades of clinical evidence, all gathered in a single comprehensive scientific white paper.

MenaQ7® is the natural, clinically proven Vitamin K2 as MK-7, backed by nearly two decades of clinical evidence, all gathered in a single comprehensive scientific white paper.

 

A comprehensive scientific white paper revealing insights from close to two decades of proprietary and published clinical research on MenaQ7® Vitamin K2 as MK-7 is now accessible. This document examines the proven benefits in bone and cardiovascular health, the impact of vitamin K2 status throughout various life stages, and emerging research exploring its role in brain function and metabolic health. Designed as a structured, evidence-based resource, the white paper supports R&D professionals, regulatory personnel, scientific teams, and product developers in the dietary supplement and functional food sectors.

 

A Singular Ingredient Supported by Exceptional Science 

Not all Vitamin K2 ingredients are scientifically equivalent. The bioform, manufacturing process, and clinical validation program behind an ingredient determine its credibility — and, ultimately, your product’s ability to substantiate health claims. 
 

MenaQ7® is the first and most clinically proven natural Vitamin K2 as MK-7, supported by numerous proprietary clinical studies covering all life stages. Produced through a controlled natural fermentation process using non-GMO Bacillus strains on an allergen-free substrate, MenaQ7® is a highly pure ingredient — with a general purity exceeding 97% and an isomeric purity of 99.8% in the bioactive all-trans MK-7 form.
 

This groundbreaking white paper consolidates nearly 20 years of studies, offering R&D teams, regulatory specialists, scientists, and brand owners a well-structured reference document with evidence-graded data to support key product formulation decisions.

 

Built to Serve Multidisciplinary Teams

Structured to fulfill the needs of diverse professionals, the white paper provides tailored data to assist cross-functional teams. Whether evaluating clinical evidence, strategizing health claims, or assessing ingredient quality benchmarks, this comprehensive document equips teams with the insights necessary to make informed decisions.

 

Inside the MenaQ7® Clinical White Paper

From the dual mechanism of action that directs calcium toward bone and away from arteries to randomized controlled trial data on bone strength, arterial elasticity, and coronary calcification — supported by a clinically documented safety profile — this white paper covers the full scientific rationale for formulating with MenaQ7®: 

 

Executive Summary
 

– The Vitamin K Family — chemistry, sources, and regional intake recommendations  

– MenaQ7® — manufacturing process and quality specifications 

– Pharmacokinetics and Mechanism of Action 

– The Calcium Paradox — Vitamin K2, Vitamin D, and Magnesium 

– Clinical Evidence — bone health in adults and children, cardiovascular health, vitamin K status, emerging research 

– Safety Profile 
 
Access the comprehensive scientific dossier on MenaQ7®, the most thoroughly researched Vitamin K2 ingredient worldwide. Whether focusing on its established benefits in bone and heart health or exploring emerging applications, the evidence-packed white paper provides everything necessary to guide your formulation team.

 

>> DOWNLOAD THE WHITEPAPER <<

Transform standard supplements into comprehensive performance solutions by combining magnesium with clinically validated MenaQ7®. This powerful duo addresses bone health, muscle recovery, and cardiovascular output through EFSA-authorized claims.

Transform standard supplements into comprehensive performance solutions by combining magnesium with clinically validated MenaQ7®. This powerful duo addresses bone health, muscle recovery, and cardiovascular output through EFSA-authorized claims.

 

Magnesium: Essential Mineral with Authorized European Health Claims

Athletes and active consumers rely on this essential mineral for multiple performance benefits. According to EFSA-authorized health claims, magnesium contributes to the reduction of tiredness and fatigue—essential for managing demanding training schedules and competition periods. It also supports normal muscle function and protein synthesis, enabling efficient recovery following intense exercise sessions. Additional authorized claims highlight broader wellness support. It contributes to normal functioning of the nervous system and electrolyte balance, both critical during physical exertion. Magnesium also supports maintenance of normal bones, providing structural integrity for long-term athletic participation.

These regulated claims enable European sport supplement manufacturers to communicate clear benefits that resonate with health-conscious consumers seeking reliable nutrition solutions.

 

MenaQ7® Creates Powerful Bone Health Synergy

While magnesium provides the structural groundwork, adding MenaQ7® creates a powerful synergy for skeletal health. Magnesium and Vitamin K2 work together to ensure calcium is used effectively. MenaQ7® is shown to activate osteocalcin, the protein responsible for binding calcium to the bone matrix. Without adequate Vitamin K2, bones can become weak and brittle. MenaQ7® is the most clinically validated Vitamin K2 to significantly improve bone mineral density and bone strength.

For supplement manufacturers, choosing MenaQ7®—the most clinically proven natural Vitamin K2—allows a premium performance and mobility range that offers a higher standard of bone support than magnesium alone.

 

Cardiovascular Performance and Energy Enhancement

This combination extends benefits beyond skeletal health to deliver measurable cardiovascular improvements critical for athletic achievement. While EFSA allows for a claim on normal energy-yielding for magnesium, emerging clinical research demonstrates Vitamin K2 could impact aerobic capacity during exercise.

Studies with trained athletes revealed impressive findings. Eight weeks of supplementation increased maximal cardiac output by 12% during exercise testing protocols. This improvement reflects Vitamin K2’s role in optimizing mitochondrial function and ATP production—the primary energy source powering muscle contractions during high-intensity physical activity. In fact, the study suggests that K2 supplementation could potentially reduce the training window required to achieve these cardiac improvements by approximately 60%

By expanding your magnesium portfolio with MenaQ7®, you provide a scientifically backed, multi-functional product that addresses the two most critical pillars for athletes: peak cardiovascular performance and robust skeletal mobility.

 
Do you need more information about Vitamin K2 or have any outstanding questions? Please do not hesitate to contact us; our expert team will happily answer!

 
References

1- McFarlin BK, et al. (2017). Oral Consumption of Vitamin K2 for 8 Weeks Associated With Increased Maximal Cardiac Output During Exercise. Altern Ther Health Med.

2- Knapen MHJ, et al. (2013). Three-year low-dose vitamin K2 supplementation helps decrease bone loss in healthy postmenopausal women. Osteoporosis International.

3- van Summeren MJ, et al. (2009). The effect of menaquinone-7 supplementation on osteocalcin carboxylation in healthy children. British Journal of Nutrition.

4- EU Health Claims Register. Authorized health claims for Magnesium (Reduction of tiredness, muscle function, protein synthesis, nervous system, and bone maintenance).

 

>> CONTACT US <<

Understanding the Link Between Nutritional Deficiencies and Heart Disease.

Understanding the Link Between Nutritional Deficiencies and Heart Disease

 
As cardiovascular disease continues to be the leading cause of mortality globally, emerging research reveals a critical gap in prevention strategies: widespread deficiencies in Vitamin K2 and folate (Vitamin B9) may be significantly contributing to heart disease risk, often beginning as early as their 20s.

 
Clinicians from the Cleveland Clinic Foundation have stated: “There is an alarmingly high prevalence of vitamin K deficiency and suboptimal recommended intake among the general population in the US.” Meanwhile, 73% of women of reproductive age have insufficient folate levels—affecting not just pregnancy outcomes but long-term cardiovascular health.

 

The Cardiovascular Impact of Vitamin K2 Deficiency

How Vitamin K2 Protects Your Arteries
Vitamin K2 plays a crucial role in calcium metabolism, directing calcium to bones while stopping its harmful accumulation in arteries. It activates Matrix Gla-protein (MGP), a key inhibitor of vascular calcification. Without adequate Vitamin K2, calcium deposits in arterial walls, leading to stiffness, atherosclerosis, and increased cardiovascular mortality.

The protective effect is quantifiable: each additional 10 micrograms of Vitamin K2 consumed daily is associated with a 9% lower risk of coronary heart disease. The Council for Responsible Nutrition estimates that widespread Vitamin K2 supplementation could reduce coronary artery disease events by 15.7% and save the U.S. healthcare system $9.48 billion between 2022 and 2030.

 
Clinical Evidence: The VitaK CAC Trial
Recent results from the VitaK CAC trial demonstrate that two years of Vitamin K2 (MK-7) supplementation significantly slowed coronary artery calcification compared with placebo. Previous studies show that long-term MK-7 supplementation improves vascular elasticity and supports healthy blood pressure, particularly in postmenopausal women with elevated arterial stiffness.

 

Folate Deficiency and Compromised Heart Health

The Homocysteine Connection
Approximately 54% of the world’s population does not consume adequate folate from diet alone. Folate is essential for homocysteine metabolism—elevated homocysteine damages blood vessel linings and significantly increases cardiovascular risk.

 
Active Folate vs. Folic Acid: Why It Matters
A critical distinction: folic acid (synthetic form in most supplements) requires enzymatic conversion to become bioavailable. Approximately 40% of the population carries MTHFR genetic variations that impair this conversion, making folic acid supplementation ineffective for these individuals.

 
Active folate (5-MTHF) bypasses this conversion step entirely, delivering the nutrient in its immediately usable form regardless of genetic status. This ensures optimal absorption and cardiovascular protection for all individuals.

 

A Complementary Approach to Heart Health

Vitamin K2 and active folate address two distinct but complementary cardiovascular pathways:
 
Calcium regulation: Vitamin K2 activates Matrix Gla-protein, preventing arterial calcification while supporting bone health.
 
Homocysteine metabolism: Active folate reduces homocysteine levels, supporting endothelial function and vascular health.
 
Both nutrients are backed by extensive clinical research demonstrating measurable cardiovascular benefits. Given that cardiovascular disease development begins decades before symptoms emerge, addressing these nutritional deficiencies through targeted supplementation represents a significant preventive opportunity.

 

Why Diet Alone Isn’t Enough

According to Lacey Hall, MS, RD, Head of Medical Affairs with Gnosis by Lesaffre: “It is difficult for most consumers to overhaul their current diets as the convenience of preparation is the top priority, resulting in low levels of key nutrients. Now more than ever, supplementation to fill the gaps is easy and attractive.”
 
Vitamin K2 is found primarily in fermented foods (like natto) and certain cheeses—foods many consume infrequently. Folate bioavailability from leafy greens and legumes is reduced by cooking and processing. Modern Western diets, dominated by convenience foods, make obtaining optimal levels of these nutrients through diet alone increasingly challenging.

 

Key Takeaways for Cardiovascular Health Protection

1- Deficiency is widespread: 73% of women and a significant portion of the general population are deficient in these critical heart-protective nutrients

2- The impact is measurable: Vitamin K2 reduces coronary heart disease risk by 9% per 10 mcg consumed; folate reduces cardiovascular mortality by 10%

3- Genetics matter: 40% of people cannot effectively convert folic acid, making active folate supplementation essential

4- Prevention starts early: Arterial calcification and endothelial dysfunction develop over decades, making early intervention crucial

5- Clinical validation: Recent trials demonstrate significant reductions in coronary artery calcification with Vitamin K2 supplementation

 

Conclusion: Beyond Cholesterol in Heart Health

As cardiovascular strategies evolve beyond traditional cholesterol management, scientific evidence increasingly supports comprehensive nutritional approaches. Optimizing Vitamin K2 and folate status through evidence-based supplementation addresses vascular aging at the molecular level, stopping arterial calcification and supporting long-term cardiovascular health.
 
With cardiovascular disease beginning in early adulthood and progressing silently for decades, addressing these common nutritional deficiencies represents a practical, scientifically validated approach to heart health strategies.

 
References
1- Hariri E, et al. Vitamin K2—a neglected player in cardiovascular health. Open Heart. 2021;8(2):e001715.

2- Gast GC, et al. A high menaquinone intake reduces the incidence of coronary heart disease. Nutr Metab Cardiovasc Dis. 2009;19(7):504-510.

3- Koulman A, et al. Folate status and urgency for folate fortification. Eur J Nutr. 2025;64(6):272.

4- Fallah M, et al. Folate Biomarkers and Risk of Death From Cardiovascular Disease. Nutrition Reviews. 2025;83(3):e801-e813.